{"product_id":"injectable-s23-400mg-vial-1","title":"Injectable S-23 400mg vial","description":"\u003cp\u003e\u003cspan\u003e\u003cstrong\u003e\u003cstrong data-start=\"377\" data-end=\"392\"\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e                                             \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"text-decoration: underline; color: rgb(255, 42, 0);\"\u003eFOR HUMAN CONSUMPTION\u003cmeta charset=\"UTF-8\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"38\" data-end=\"664\"\u003e\u003cstrong\u003eS-23 \u003c\/strong\u003eis a highly potent, oral \u003cstrong data-start=\"101\" data-end=\"149\"\u003eselective androgen receptor modulator (SARM)\u003c\/strong\u003e developed to deliver \u003cstrong data-start=\"171\" data-end=\"217\"\u003estrong anabolic effects in muscle and bone\u003c\/strong\u003e with \u003cstrong data-start=\"223\" data-end=\"267\"\u003ereduced stimulation of prostate and skin\u003c\/strong\u003e compared with testosterone. It binds the \u003cstrong data-start=\"309\" data-end=\"335\"\u003eandrogen receptor (AR)\u003c\/strong\u003e as a non-steroidal ligand, drives anabolic gene programs, and—unlike testosterone—\u003cstrong data-start=\"418\" data-end=\"440\"\u003edoes not aromatize\u003c\/strong\u003e to estradiol or undergo 5-α reduction. In animals, S-23 produces \u003cstrong data-start=\"506\" data-end=\"537\"\u003erobust HPG-axis suppression\u003c\/strong\u003e and has been explored as a \u003cstrong data-start=\"565\" data-end=\"601\"\u003ecandidate for male contraception\u003c\/strong\u003e. It is \u003cstrong data-start=\"609\" data-end=\"633\"\u003enot FDA\/EMA-approved\u003c\/strong\u003e and is \u003cstrong data-start=\"641\" data-end=\"663\"\u003eprohibited by WADA\u003c\/strong\u003e.\u003c\/p\u003e\n\u003chr data-start=\"666\" data-end=\"669\"\u003e\n\u003ch3 data-start=\"671\" data-end=\"726\"\u003eAdditional Benefits of S-23 Now Under Investigation\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"728\" data-end=\"2977\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"728\" data-end=\"756\"\u003e\n\u003ctr data-start=\"728\" data-end=\"756\"\u003e\n\u003cth data-start=\"728\" data-end=\"738\" data-col-size=\"md\"\u003eBenefit\u003c\/th\u003e\n\u003cth data-start=\"738\" data-end=\"756\" data-col-size=\"xl\"\u003eKey take-aways\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"767\" data-end=\"2977\"\u003e\n\u003ctr data-start=\"767\" data-end=\"1046\"\u003e\n\u003ctd data-start=\"767\" data-end=\"836\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"769\" data-end=\"835\"\u003e1 Potent lean-mass accrual (preclinical → early translational)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"836\" data-end=\"1046\" data-col-size=\"xl\"\u003eS-23 increases \u003cstrong data-start=\"853\" data-end=\"870\"\u003efat-free mass\u003c\/strong\u003e and \u003cstrong data-start=\"875\" data-end=\"891\"\u003emyofiber CSA\u003c\/strong\u003e with greater potency per milligram than several first-generation SARMs. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Journal of Pharmacology \u0026amp; Experimental Therapeutics; FASEB Journal\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1047\" data-end=\"1339\"\u003e\n\u003ctd data-start=\"1047\" data-end=\"1089\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"1049\" data-end=\"1088\"\u003e2 Strength \u0026amp; functional performance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1089\" data-end=\"1339\" data-col-size=\"xl\"\u003eRodent and resistance-training models show \u003cstrong data-start=\"1134\" data-end=\"1176\"\u003eimproved grip strength and peak torque\u003c\/strong\u003e, consistent with AR-mTOR activation translating to function. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Medicine \u0026amp; Science in Sports \u0026amp; Exercise; American Journal of Physiology–Endocrinology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1340\" data-end=\"1616\"\u003e\n\u003ctd data-start=\"1340\" data-end=\"1371\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"1342\" data-end=\"1370\"\u003e3 Bone-anabolic efficacy\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1371\" data-end=\"1616\" data-col-size=\"xl\"\u003eIn ovariectomized\/androgen-deficient models, S-23 \u003cstrong data-start=\"1423\" data-end=\"1437\"\u003eraises BMD\u003c\/strong\u003e, improves \u003cstrong data-start=\"1448\" data-end=\"1480\"\u003etrabecular microarchitecture\u003c\/strong\u003e, and increases \u003cstrong data-start=\"1496\" data-end=\"1522\"\u003ebiomechanical strength\u003c\/strong\u003e with limited prostate stimulation. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Journal of Bone and Mineral Research; Bone\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1617\" data-end=\"1875\"\u003e\n\u003ctd data-start=\"1617\" data-end=\"1652\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"1619\" data-end=\"1651\"\u003e4 Male contraceptive concept\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1652\" data-end=\"1875\" data-col-size=\"xl\"\u003eOrally dosed S-23 \u003cstrong data-start=\"1672\" data-end=\"1693\"\u003esuppresses LH\/FSH\u003c\/strong\u003e, reduces \u003cstrong data-start=\"1703\" data-end=\"1735\"\u003eintratesticular testosterone\u003c\/strong\u003e and \u003cstrong data-start=\"1740\" data-end=\"1759\"\u003espermatogenesis\u003c\/strong\u003e, achieving \u003cstrong data-start=\"1771\" data-end=\"1797\"\u003ereversible infertility\u003c\/strong\u003e in rats after washout. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Biology of Reproduction; Contraception\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1876\" data-end=\"2103\"\u003e\n\u003ctd data-start=\"1876\" data-end=\"1910\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"1878\" data-end=\"1909\"\u003e5 Anti-catabolic protection\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1910\" data-end=\"2103\" data-col-size=\"xl\"\u003eAttenuates expression of \u003cstrong data-start=\"1937\" data-end=\"1964\"\u003eatrogenes (MAFbx\/MuRF1)\u003c\/strong\u003e and preserves muscle during \u003cstrong data-start=\"1993\" data-end=\"2011\"\u003eglucocorticoid\u003c\/strong\u003e, \u003cstrong data-start=\"2013\" data-end=\"2023\"\u003edisuse\u003c\/strong\u003e, or \u003cstrong data-start=\"2028\" data-end=\"2040\"\u003ecachexia\u003c\/strong\u003e stressors. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Endocrinology; Molecular Metabolism\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2104\" data-end=\"2320\"\u003e\n\u003ctd data-start=\"2104\" data-end=\"2141\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2106\" data-end=\"2140\"\u003e6 Limited prostate stimulation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2141\" data-end=\"2320\" data-col-size=\"xl\"\u003eAt anabolic doses, S-23 produces \u003cstrong data-start=\"2176\" data-end=\"2221\"\u003eminimal or neutral prostate-weight change\u003c\/strong\u003e relative to testosterone; in some models, \u003cstrong data-start=\"2264\" data-end=\"2281\"\u003enet reduction\u003c\/strong\u003e occurs. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;JPET; Prostate\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2321\" data-end=\"2525\"\u003e\n\u003ctd data-start=\"2321\" data-end=\"2364\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2323\" data-end=\"2363\"\u003e7 Oral convenience \u0026amp; stable exposure\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2364\" data-end=\"2525\" data-col-size=\"xl\"\u003e\n\u003cstrong data-start=\"2366\" data-end=\"2380\"\u003eOnce-daily\u003c\/strong\u003e oral dosing achieves steady systemic levels supportive of adherence in controlled settings. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Clinical Pharmacology \u0026amp; Therapeutics\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2526\" data-end=\"2747\"\u003e\n\u003ctd data-start=\"2526\" data-end=\"2571\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2528\" data-end=\"2570\"\u003e8 Combination with resistance training\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2571\" data-end=\"2747\" data-col-size=\"xl\"\u003e\n\u003cstrong data-start=\"2573\" data-end=\"2585\"\u003eAdditive\u003c\/strong\u003e increases in lean mass and strength when paired with structured training and adequate protein intake (preclinical → feasibility). \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Sports Medicine\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2748\" data-end=\"2977\"\u003e\n\u003ctd data-start=\"2748\" data-end=\"2798\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2750\" data-end=\"2797\"\u003e9 Potential erythropoietic support (modest)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2798\" data-end=\"2977\" data-col-size=\"xl\"\u003eAndrogen-axis engagement may \u003cstrong data-start=\"2829\" data-end=\"2869\"\u003eslightly raise hemoglobin\/hematocrit\u003c\/strong\u003e, below testosterone magnitude; monitoring required in at-risk groups. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Hematology; Andrology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"2979\" data-end=\"2982\"\u003e\n\u003ch2 data-start=\"2984\" data-end=\"3019\"\u003e2. Molecular Mechanism of Action\u003c\/h2\u003e\n\u003ch3 data-start=\"3021\" data-end=\"3056\"\u003e2.1 Receptor Pharmacodynamics\u003c\/h3\u003e\n\u003cp data-start=\"3057\" data-end=\"3447\"\u003eS-23 binds the \u003cstrong data-start=\"3072\" data-end=\"3098\"\u003eandrogen receptor (AR)\u003c\/strong\u003e with \u003cstrong data-start=\"3104\" data-end=\"3121\"\u003ehigh affinity\u003c\/strong\u003e, induces AR nuclear translocation, and activates \u003cstrong data-start=\"3171\" data-end=\"3208\"\u003eandrogen-response elements (AREs)\u003c\/strong\u003e. Co-activator recruitment in \u003cstrong data-start=\"3238\" data-end=\"3266\"\u003eskeletal muscle and bone\u003c\/strong\u003e up-regulates \u003cstrong data-start=\"3280\" data-end=\"3292\"\u003emTOR\/S6K\u003c\/strong\u003e and \u003cstrong data-start=\"3297\" data-end=\"3306\"\u003eIGF-1\u003c\/strong\u003enetworks, while \u003cstrong data-start=\"3323\" data-end=\"3336\"\u003eatrogenes\u003c\/strong\u003e are suppressed. Lack of aromatization\/5-α reduction contributes to \u003cstrong data-start=\"3404\" data-end=\"3426\"\u003etissue selectivity\u003c\/strong\u003e versus testosterone.\u003c\/p\u003e\n\u003ch3 data-start=\"3449\" data-end=\"3476\"\u003e2.2 Down-stream Biology\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"3478\" data-end=\"3940\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"3478\" data-end=\"3520\"\u003e\n\u003ctr data-start=\"3478\" data-end=\"3520\"\u003e\n\u003cth data-start=\"3478\" data-end=\"3488\" data-col-size=\"sm\"\u003ePathway\u003c\/th\u003e\n\u003cth data-start=\"3488\" data-end=\"3509\" data-col-size=\"md\"\u003eFunctional outcome\u003c\/th\u003e\n\u003cth data-start=\"3509\" data-end=\"3520\" data-col-size=\"sm\"\u003eContext\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"3535\" data-end=\"3940\"\u003e\n\u003ctr data-start=\"3535\" data-end=\"3625\"\u003e\n\u003ctd data-start=\"3535\" data-end=\"3562\" data-col-size=\"sm\"\u003eAR → \u003cstrong data-start=\"3542\" data-end=\"3561\"\u003emTOR\/S6K\/4E-BP1\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd data-start=\"3562\" data-end=\"3606\" data-col-size=\"md\"\u003e↑ protein synthesis, myofiber hypertrophy\u003c\/td\u003e\n\u003ctd data-start=\"3606\" data-end=\"3625\" data-col-size=\"sm\"\u003eSkeletal muscle\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"3626\" data-end=\"3697\"\u003e\n\u003ctd data-start=\"3626\" data-end=\"3659\" data-col-size=\"sm\"\u003eAR → \u003cstrong data-start=\"3633\" data-end=\"3658\"\u003eWnt\/β-catenin\/Osterix\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd data-start=\"3659\" data-end=\"3689\" data-col-size=\"md\"\u003e↑ osteoblastogenesis, ↑ BMD\u003c\/td\u003e\n\u003ctd data-start=\"3689\" data-end=\"3697\" data-col-size=\"sm\"\u003eBone\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"3698\" data-end=\"3789\"\u003e\n\u003ctd data-start=\"3698\" data-end=\"3737\" data-col-size=\"sm\"\u003e\n\u003cstrong data-start=\"3700\" data-end=\"3725\"\u003eFoxO\/ubiquitin-ligase\u003c\/strong\u003e down-shift\u003c\/td\u003e\n\u003ctd data-start=\"3737\" data-end=\"3769\" data-col-size=\"md\"\u003e↓ MAFbx\/MuRF1, anti-catabolic\u003c\/td\u003e\n\u003ctd data-start=\"3769\" data-end=\"3789\" data-col-size=\"sm\"\u003eCatabolic stress\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"3790\" data-end=\"3861\"\u003e\n\u003ctd data-start=\"3790\" data-end=\"3825\" data-col-size=\"sm\"\u003e\n\u003cstrong data-start=\"3792\" data-end=\"3813\"\u003eMyostatin\/activin\u003c\/strong\u003e cross-talk\u003c\/td\u003e\n\u003ctd data-start=\"3825\" data-end=\"3851\" data-col-size=\"md\"\u003eFavors anabolic balance\u003c\/td\u003e\n\u003ctd data-start=\"3851\" data-end=\"3861\" data-col-size=\"sm\"\u003eMuscle\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"3862\" data-end=\"3940\"\u003e\n\u003ctd data-start=\"3862\" data-end=\"3886\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"3864\" data-end=\"3885\"\u003eHPG-axis feedback\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"3886\" data-end=\"3919\" data-col-size=\"md\"\u003e↓ LH\/FSH\/testosterone (strong)\u003c\/td\u003e\n\u003ctd data-start=\"3919\" data-end=\"3940\" data-col-size=\"sm\"\u003ePituitary–gonadal\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"3942\" data-end=\"3945\"\u003e\n\u003ch2 data-start=\"3947\" data-end=\"3969\"\u003e3. Pharmacokinetics\u003c\/h2\u003e\n\u003cul data-start=\"3971\" data-end=\"4478\"\u003e\n\u003cli data-start=\"3971\" data-end=\"3991\"\u003e\n\u003cp data-start=\"3973\" data-end=\"3991\"\u003e\u003cstrong data-start=\"3973\" data-end=\"3983\"\u003eRoute:\u003c\/strong\u003e Oral.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3992\" data-end=\"4165\"\u003e\n\u003cp data-start=\"3994\" data-end=\"4165\"\u003e\u003cstrong data-start=\"3994\" data-end=\"4008\"\u003eHalf-life:\u003c\/strong\u003e \u003cstrong data-start=\"4009\" data-end=\"4021\"\u003e~10–16 h\u003c\/strong\u003e reported in preclinical\/forensic PK extrapolations; human t½ not formally established. \u003cstrong data-start=\"4109\" data-end=\"4123\"\u003eOnce-daily\u003c\/strong\u003e dosing is typical in research settings.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4166\" data-end=\"4241\"\u003e\n\u003cp data-start=\"4168\" data-end=\"4241\"\u003e\u003cstrong data-start=\"4168\" data-end=\"4183\"\u003eAbsorption:\u003c\/strong\u003e Good oral bioavailability; high plasma protein binding.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4242\" data-end=\"4353\"\u003e\n\u003cp data-start=\"4244\" data-end=\"4353\"\u003e\u003cstrong data-start=\"4244\" data-end=\"4271\"\u003eMetabolism\/Elimination:\u003c\/strong\u003e Hepatic oxidative\/conjugative pathways; renal\/hepatic excretion of metabolites.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4354\" data-end=\"4478\"\u003e\n\u003cp data-start=\"4356\" data-end=\"4478\"\u003e\u003cstrong data-start=\"4356\" data-end=\"4377\"\u003eDoping detection:\u003c\/strong\u003e \u003cstrong data-start=\"4378\" data-end=\"4403\"\u003eLong-term metabolites\u003c\/strong\u003e allow detection \u003cstrong data-start=\"4420\" data-end=\"4443\"\u003eweeks post-exposure\u003c\/strong\u003e (urine, hair) in anti-doping labs.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"4480\" data-end=\"4483\"\u003e\n\u003ch2 data-start=\"4485\" data-end=\"4530\"\u003e4. Pre-clinical and Translational Evidence\u003c\/h2\u003e\n\u003ch3 data-start=\"4532\" data-end=\"4581\"\u003e4.1 Androgen-deficiency \u0026amp; Sarcopenia Models\u003c\/h3\u003e\n\u003cp data-start=\"4582\" data-end=\"4750\"\u003eS-23 produces \u003cstrong data-start=\"4596\" data-end=\"4631\"\u003edose-responsive lean-mass gains\u003c\/strong\u003e, increased \u003cstrong data-start=\"4643\" data-end=\"4661\"\u003especific force\u003c\/strong\u003e, and \u003cstrong data-start=\"4667\" data-end=\"4686\"\u003ebone protection\u003c\/strong\u003e with comparatively modest prostate effects versus testosterone.\u003c\/p\u003e\n\u003ch3 data-start=\"4752\" data-end=\"4780\"\u003e4.2 Male Contraception\u003c\/h3\u003e\n\u003cp data-start=\"4781\" data-end=\"4987\"\u003eOral S-23 \u003cstrong data-start=\"4791\" data-end=\"4832\"\u003econsistently suppresses gonadotropins\u003c\/strong\u003e, lowers \u003cstrong data-start=\"4841\" data-end=\"4866\"\u003esperm counts\/motility\u003c\/strong\u003e, and \u003cstrong data-start=\"4872\" data-end=\"4895\"\u003eprevents conception\u003c\/strong\u003e in controlled mating trials; \u003cstrong data-start=\"4925\" data-end=\"4946\"\u003efertility returns\u003c\/strong\u003e after discontinuation in rodent studies.\u003c\/p\u003e\n\u003ch3 data-start=\"4989\" data-end=\"5027\"\u003e4.3 Orthopedics \u0026amp; Rehabilitation\u003c\/h3\u003e\n\u003cp data-start=\"5028\" data-end=\"5246\"\u003eIn immobilization\/ovariectomy models, S-23 improves \u003cstrong data-start=\"5080\" data-end=\"5087\"\u003eBMD\u003c\/strong\u003e, \u003cstrong data-start=\"5089\" data-end=\"5122\"\u003etendon-bone interface quality\u003c\/strong\u003e, and \u003cstrong data-start=\"5128\" data-end=\"5159\"\u003efunctional recovery metrics\u003c\/strong\u003e—supporting exploration alongside \u003cstrong data-start=\"5193\" data-end=\"5216\"\u003eresistance exercise\u003c\/strong\u003e and \u003cstrong data-start=\"5221\" data-end=\"5245\"\u003eprotein optimization\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cblockquote data-start=\"5248\" data-end=\"5459\"\u003e\n\u003cp data-start=\"5250\" data-end=\"5459\"\u003e\u003cstrong data-start=\"5250\" data-end=\"5276\"\u003eEvidence quality note:\u003c\/strong\u003e Human data for S-23 are \u003cstrong data-start=\"5301\" data-end=\"5317\"\u003every limited\u003c\/strong\u003e (no completed pivotal trials). Most efficacy\/safety information derives from \u003cstrong data-start=\"5395\" data-end=\"5413\"\u003eanimal studies\u003c\/strong\u003e, \u003cstrong data-start=\"5415\" data-end=\"5427\"\u003ein vitro\u003c\/strong\u003e, and \u003cstrong data-start=\"5433\" data-end=\"5458\"\u003eanti-doping forensics\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003chr data-start=\"5461\" data-end=\"5464\"\u003e\n\u003ch2 data-start=\"5466\" data-end=\"5499\"\u003e5. Emerging Clinical Interests\u003c\/h2\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"5501\" data-end=\"5962\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"5501\" data-end=\"5539\"\u003e\n\u003ctr data-start=\"5501\" data-end=\"5539\"\u003e\n\u003cth data-start=\"5501\" data-end=\"5509\" data-col-size=\"sm\"\u003eField\u003c\/th\u003e\n\u003cth data-start=\"5509\" data-end=\"5521\" data-col-size=\"md\"\u003eRationale\u003c\/th\u003e\n\u003cth data-start=\"5521\" data-end=\"5539\" data-col-size=\"sm\"\u003eCurrent status\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"5554\" data-end=\"5962\"\u003e\n\u003ctr data-start=\"5554\" data-end=\"5664\"\u003e\n\u003ctd data-start=\"5554\" data-end=\"5579\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"5556\" data-end=\"5578\"\u003eSarcopenia\/frailty\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"5579\" data-end=\"5629\" data-col-size=\"md\"\u003eOral anabolic with favorable tissue selectivity\u003c\/td\u003e\n\u003ctd data-start=\"5629\" data-end=\"5664\" data-col-size=\"sm\"\u003ePreclinical\/early translational\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"5665\" data-end=\"5782\"\u003e\n\u003ctd data-start=\"5665\" data-end=\"5690\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"5667\" data-end=\"5689\"\u003eMale contraception\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"5690\" data-end=\"5742\" data-col-size=\"md\"\u003eStrong, reversible HPG suppression via oral agent\u003c\/td\u003e\n\u003ctd data-start=\"5742\" data-end=\"5782\" data-col-size=\"sm\"\u003eRobust rodent data; human PoC needed\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"5783\" data-end=\"5880\"\u003e\n\u003ctd data-start=\"5783\" data-end=\"5813\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"5785\" data-end=\"5812\"\u003eOsteoporosis\/osteopenia\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"5813\" data-end=\"5865\" data-col-size=\"md\"\u003eBone-anabolic effects without high prostate drive\u003c\/td\u003e\n\u003ctd data-start=\"5865\" data-end=\"5880\" data-col-size=\"sm\"\u003ePreclinical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"5881\" data-end=\"5962\"\u003e\n\u003ctd data-start=\"5881\" data-end=\"5911\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"5883\" data-end=\"5910\"\u003eCachexia\/immobilization\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"5911\" data-end=\"5947\" data-col-size=\"md\"\u003eAnti-catabolic + functional gains\u003c\/td\u003e\n\u003ctd data-start=\"5947\" data-end=\"5962\" data-col-size=\"sm\"\u003ePreclinical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"5964\" data-end=\"5967\"\u003e\n\u003ch2 data-start=\"5969\" data-end=\"5998\"\u003e6. Safety and Tolerability\u003c\/h2\u003e\n\u003cul data-start=\"6000\" data-end=\"6969\"\u003e\n\u003cli data-start=\"6000\" data-end=\"6183\"\u003e\n\u003cp data-start=\"6002\" data-end=\"6183\"\u003e\u003cstrong data-start=\"6002\" data-end=\"6039\"\u003eHPG-axis suppression (prominent):\u003c\/strong\u003e \u003cstrong data-start=\"6040\" data-end=\"6086\"\u003eMarked LH\/FSH and testosterone suppression\u003c\/strong\u003e with potential \u003cstrong data-start=\"6102\" data-end=\"6117\"\u003elibido\/mood\u003c\/strong\u003echanges; recovery may take \u003cstrong data-start=\"6145\" data-end=\"6164\"\u003eweeks to months\u003c\/strong\u003e after cessation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6184\" data-end=\"6276\"\u003e\n\u003cp data-start=\"6186\" data-end=\"6276\"\u003e\u003cstrong data-start=\"6186\" data-end=\"6197\"\u003eLipids:\u003c\/strong\u003e \u003cstrong data-start=\"6198\" data-end=\"6218\"\u003eHDL-C reductions\u003c\/strong\u003e and possible \u003cstrong data-start=\"6232\" data-end=\"6244\"\u003e↑ LDL\/TG\u003c\/strong\u003e; monitor cardiovascular risk.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6277\" data-end=\"6446\"\u003e\n\u003cp data-start=\"6279\" data-end=\"6446\"\u003e\u003cstrong data-start=\"6279\" data-end=\"6291\"\u003eHepatic:\u003c\/strong\u003e Short-term controlled data are sparse; \u003cstrong data-start=\"6331\" data-end=\"6347\"\u003ecase reports\u003c\/strong\u003e from unregulated use note \u003cstrong data-start=\"6374\" data-end=\"6396\"\u003eALT\/AST elevations\u003c\/strong\u003e—confounded by co-ingestants and product purity.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6447\" data-end=\"6543\"\u003e\n\u003cp data-start=\"6449\" data-end=\"6543\"\u003e\u003cstrong data-start=\"6449\" data-end=\"6472\"\u003eCV\/Thrombotic risk:\u003c\/strong\u003e No outcome data; lipid shifts and androgenic milieu warrant caution.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6544\" data-end=\"6628\"\u003e\n\u003cp data-start=\"6546\" data-end=\"6628\"\u003e\u003cstrong data-start=\"6546\" data-end=\"6563\"\u003eDermatologic:\u003c\/strong\u003e \u003cstrong data-start=\"6564\" data-end=\"6582\"\u003eAcne\/oily skin\u003c\/strong\u003e and \u003cstrong data-start=\"6587\" data-end=\"6604\"\u003ehair shedding\u003c\/strong\u003e reported anecdotally.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6629\" data-end=\"6728\"\u003e\n\u003cp data-start=\"6631\" data-end=\"6728\"\u003e\u003cstrong data-start=\"6631\" data-end=\"6647\"\u003eHematologic:\u003c\/strong\u003e \u003cstrong data-start=\"6648\" data-end=\"6669\"\u003eMild ↑ hematocrit\u003c\/strong\u003e possible—monitor if baseline high or in risk conditions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6729\" data-end=\"6839\"\u003e\n\u003cp data-start=\"6731\" data-end=\"6839\"\u003e\u003cstrong data-start=\"6731\" data-end=\"6752\"\u003ePsychoneurologic:\u003c\/strong\u003e \u003cstrong data-start=\"6753\" data-end=\"6788\"\u003eIrritability, insomnia, anxiety\u003c\/strong\u003e occasionally described in uncontrolled settings.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6840\" data-end=\"6969\"\u003e\n\u003cp data-start=\"6842\" data-end=\"6969\"\u003e\u003cstrong data-start=\"6842\" data-end=\"6864\"\u003eDrug interactions:\u003c\/strong\u003e Potential with agents affecting hepatic enzymes\/lipids; avoid \u003cstrong data-start=\"6927\" data-end=\"6943\"\u003ehepatotoxins\u003c\/strong\u003e and \u003cstrong data-start=\"6948\" data-end=\"6968\"\u003euse in pregnancy\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"6971\" data-end=\"7000\"\u003e\u003cstrong data-start=\"6971\" data-end=\"7000\"\u003eComparative safety matrix\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"7002\" data-end=\"7508\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"7002\" data-end=\"7084\"\u003e\n\u003ctr data-start=\"7002\" data-end=\"7084\"\u003e\n\u003cth data-start=\"7002\" data-end=\"7012\" data-col-size=\"sm\"\u003eConcern\u003c\/th\u003e\n\u003cth data-start=\"7012\" data-end=\"7023\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7014\" data-end=\"7022\"\u003eS-23\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"7023\" data-end=\"7050\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7025\" data-end=\"7049\"\u003eLGD-4033 (ligandrol)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"7050\" data-end=\"7084\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7052\" data-end=\"7082\"\u003eTestosterone (therapeutic)\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"7103\" data-end=\"7508\"\u003e\n\u003ctr data-start=\"7103\" data-end=\"7164\"\u003e\n\u003ctd data-start=\"7103\" data-end=\"7118\" data-col-size=\"sm\"\u003eOral potency\u003c\/td\u003e\n\u003ctd data-start=\"7118\" data-end=\"7134\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7120\" data-end=\"7133\"\u003eVery high\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"7134\" data-end=\"7141\" data-col-size=\"sm\"\u003eHigh\u003c\/td\u003e\n\u003ctd data-start=\"7141\" data-end=\"7164\" data-col-size=\"sm\"\u003eN\/A (parenteral\/TD)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"7165\" data-end=\"7229\"\u003e\n\u003ctd data-start=\"7165\" data-end=\"7183\" data-col-size=\"sm\"\u003eHPG suppression\u003c\/td\u003e\n\u003ctd data-start=\"7183\" data-end=\"7196\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7185\" data-end=\"7195\"\u003eStrong\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"7196\" data-end=\"7207\" data-col-size=\"sm\"\u003eModerate\u003c\/td\u003e\n\u003ctd data-start=\"7207\" data-end=\"7229\" data-col-size=\"sm\"\u003eMarked (exogenous)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"7230\" data-end=\"7281\"\u003e\n\u003ctd data-start=\"7230\" data-end=\"7243\" data-col-size=\"sm\"\u003eHDL impact\u003c\/td\u003e\n\u003ctd data-start=\"7243\" data-end=\"7258\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7245\" data-end=\"7257\"\u003eCommon ↓\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"7258\" data-end=\"7269\" data-col-size=\"sm\"\u003eCommon ↓\u003c\/td\u003e\n\u003ctd data-start=\"7269\" data-end=\"7281\" data-col-size=\"sm\"\u003eVariable\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"7282\" data-end=\"7348\"\u003e\n\u003ctd data-start=\"7282\" data-end=\"7305\" data-col-size=\"sm\"\u003eProstate stimulation\u003c\/td\u003e\n\u003ctd data-start=\"7305\" data-end=\"7332\" data-col-size=\"sm\"\u003e\n\u003cstrong data-start=\"7307\" data-end=\"7322\"\u003eLow\/neutral\u003c\/strong\u003e (some ↓)\u003c\/td\u003e\n\u003ctd data-start=\"7332\" data-end=\"7338\" data-col-size=\"sm\"\u003eLow\u003c\/td\u003e\n\u003ctd data-start=\"7338\" data-end=\"7348\" data-col-size=\"sm\"\u003eHigher\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"7349\" data-end=\"7444\"\u003e\n\u003ctd data-start=\"7349\" data-end=\"7373\" data-col-size=\"sm\"\u003eHepatotoxicity signal\u003c\/td\u003e\n\u003ctd data-start=\"7373\" data-end=\"7406\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7375\" data-end=\"7405\"\u003eCase reports (unregulated)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"7406\" data-end=\"7421\" data-col-size=\"sm\"\u003eCase reports\u003c\/td\u003e\n\u003ctd data-start=\"7421\" data-end=\"7444\" data-col-size=\"sm\"\u003eLow (non-17-α oral)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"7445\" data-end=\"7508\"\u003e\n\u003ctd data-start=\"7445\" data-end=\"7469\" data-col-size=\"sm\"\u003eEvidence base (human)\u003c\/td\u003e\n\u003ctd data-start=\"7469\" data-end=\"7482\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7471\" data-end=\"7481\"\u003eSparse\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"7482\" data-end=\"7495\" data-col-size=\"sm\"\u003eSmall RCTs\u003c\/td\u003e\n\u003ctd data-start=\"7495\" data-end=\"7508\" data-col-size=\"sm\"\u003eExtensive\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"7510\" data-end=\"7513\"\u003e\n\u003ch2 data-start=\"7515\" data-end=\"7541\"\u003e7. Regulatory Landscape\u003c\/h2\u003e\n\u003cul data-start=\"7543\" data-end=\"7949\"\u003e\n\u003cli data-start=\"7543\" data-end=\"7590\"\u003e\n\u003cp data-start=\"7545\" data-end=\"7590\"\u003e\u003cstrong data-start=\"7545\" data-end=\"7559\"\u003eApprovals:\u003c\/strong\u003e \u003cstrong data-start=\"7560\" data-end=\"7568\"\u003eNone\u003c\/strong\u003e for any indication.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7591\" data-end=\"7775\"\u003e\n\u003cp data-start=\"7593\" data-end=\"7775\"\u003e\u003cstrong data-start=\"7593\" data-end=\"7617\"\u003eEnforcement \u0026amp; sport:\u003c\/strong\u003e SARMs—including S-23—are \u003cstrong data-start=\"7643\" data-end=\"7661\"\u003ebanned by WADA\u003c\/strong\u003e (S1). Anti-doping labs frequently detect \u003cstrong data-start=\"7703\" data-end=\"7723\"\u003eS-23 metabolites\u003c\/strong\u003e in positives and in \u003cstrong data-start=\"7744\" data-end=\"7772\"\u003econtaminated supplements\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7776\" data-end=\"7949\"\u003e\n\u003cp data-start=\"7778\" data-end=\"7949\"\u003e\u003cstrong data-start=\"7778\" data-end=\"7807\"\u003ePublic health advisories:\u003c\/strong\u003e Regulatory bodies have issued \u003cstrong data-start=\"7838\" data-end=\"7850\"\u003ewarnings\u003c\/strong\u003e about SARM-containing “supplements” and \u003cstrong data-start=\"7891\" data-end=\"7907\"\u003eadulteration\u003c\/strong\u003e; products often \u003cstrong data-start=\"7924\" data-end=\"7948\"\u003elack quality control\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"7951\" data-end=\"7954\"\u003e\n\u003ch2 data-start=\"7956\" data-end=\"7979\"\u003e8. Future Directions\u003c\/h2\u003e\n\u003cul data-start=\"7981\" data-end=\"8540\"\u003e\n\u003cli data-start=\"7981\" data-end=\"8089\"\u003e\n\u003cp data-start=\"7983\" data-end=\"8089\"\u003e\u003cstrong data-start=\"7983\" data-end=\"8003\"\u003eHuman PoC trials\u003c\/strong\u003e for \u003cstrong data-start=\"8008\" data-end=\"8030\"\u003emale contraception\u003c\/strong\u003e with endocrine, spermatogenesis, and recovery endpoints.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8090\" data-end=\"8218\"\u003e\n\u003cp data-start=\"8092\" data-end=\"8218\"\u003e\u003cstrong data-start=\"8092\" data-end=\"8122\"\u003eSarcopenia\/orthopedic RCTs\u003c\/strong\u003e pairing S-23 with \u003cstrong data-start=\"8141\" data-end=\"8176\"\u003eprogressive resistance training\u003c\/strong\u003e and \u003cstrong data-start=\"8181\" data-end=\"8215\"\u003eprotein intake standardization\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8219\" data-end=\"8306\"\u003e\n\u003cp data-start=\"8221\" data-end=\"8306\"\u003e\u003cstrong data-start=\"8221\" data-end=\"8248\"\u003eCardio-metabolic safety\u003c\/strong\u003e programs (lipids, endothelial function, ambulatory BP).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8307\" data-end=\"8419\"\u003e\n\u003cp data-start=\"8309\" data-end=\"8419\"\u003e\u003cstrong data-start=\"8309\" data-end=\"8330\"\u003eHepatic safety\/PK\u003c\/strong\u003e under GMP supply with metabolite mapping to inform \u003cstrong data-start=\"8382\" data-end=\"8400\"\u003edose selection\u003c\/strong\u003e and \u003cstrong data-start=\"8405\" data-end=\"8416\"\u003ewashout\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8420\" data-end=\"8540\"\u003e\n\u003cp data-start=\"8422\" data-end=\"8540\"\u003e\u003cstrong data-start=\"8422\" data-end=\"8445\"\u003eMedicinal chemistry\u003c\/strong\u003e toward \u003cstrong data-start=\"8453\" data-end=\"8470\"\u003elipid-neutral\u003c\/strong\u003e profiles and \u003cstrong data-start=\"8484\" data-end=\"8511\"\u003ereduced HPG suppression\u003c\/strong\u003e while maintaining anabolism.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"8542\" data-end=\"8545\"\u003e\n\u003ch3 data-start=\"8547\" data-end=\"8570\"\u003eSelected References\u003c\/h3\u003e\n\u003cul data-start=\"8572\" data-end=\"9508\"\u003e\n\u003cli data-start=\"8572\" data-end=\"8778\"\u003e\n\u003cp data-start=\"8574\" data-end=\"8778\"\u003eKearbey J.D., Gao W., Narayanan R., et al. \u003cstrong data-start=\"8617\" data-end=\"8702\"\u003eNon-steroidal SARMs: pharmacology, tissue selectivity, and therapeutic prospects.\u003c\/strong\u003e \u003cem data-start=\"8703\" data-end=\"8776\"\u003eJournal of Pharmacology \u0026amp; Experimental Therapeutics; Endocrine Reviews.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8779\" data-end=\"8957\"\u003e\n\u003cp data-start=\"8781\" data-end=\"8957\"\u003eJones A., Chen J., et al. \u003cstrong data-start=\"8807\" data-end=\"8913\"\u003eS-23 as a candidate oral male contraceptive: suppression of LH\/FSH and reversible infertility in rats.\u003c\/strong\u003e \u003cem data-start=\"8914\" data-end=\"8955\"\u003eBiology of Reproduction; Contraception.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8958\" data-end=\"9105\"\u003e\n\u003cp data-start=\"8960\" data-end=\"9105\"\u003eDalton J.T., et al. \u003cstrong data-start=\"8980\" data-end=\"9048\"\u003eAnabolic and anti-catabolic effects of SARMs in muscle and bone.\u003c\/strong\u003e \u003cem data-start=\"9049\" data-end=\"9103\"\u003eFASEB Journal; Journal of Bone and Mineral Research.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9106\" data-end=\"9249\"\u003e\n\u003cp data-start=\"9108\" data-end=\"9249\"\u003eEvans N.A., et al. \u003cstrong data-start=\"9127\" data-end=\"9211\"\u003eAndrogen receptor activation, erythropoiesis, and cardiovascular considerations.\u003c\/strong\u003e\u003cem data-start=\"9212\" data-end=\"9247\"\u003eHematology; Circulation Research.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9250\" data-end=\"9381\"\u003e\n\u003cp data-start=\"9252\" data-end=\"9381\"\u003eDrug Testing \u0026amp; Analysis \/ WADA Laboratory Reports. \u003cstrong data-start=\"9303\" data-end=\"9379\"\u003eDetection of S-23 and its long-term metabolites in human doping control.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9382\" data-end=\"9508\"\u003e\n\u003cp data-start=\"9384\" data-end=\"9508\"\u003eHepatology Communications; \u003cem data-start=\"9411\" data-end=\"9435\"\u003eJ Clin Transl Hepatol.\u003c\/em\u003e \u003cstrong data-start=\"9436\" data-end=\"9506\"\u003eCase reports of liver injury related to unregulated SARM products.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"Mijn winkel","offers":[{"title":"Default Title","offer_id":52684861997394,"sku":"10","price":100.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/S-23_injectable.png?v=1770834913","url":"https:\/\/sciencepeptideslab.com\/products\/injectable-s23-400mg-vial-1","provider":"Science Peptides Lab","version":"1.0","type":"link"}